NO ONE DREAMS OF SILVER
 

Panoptix is the most implanted trifocal IOL worldwide and delivers an exceptional high-quality visual experience from far to near, with 99% patient satisfaction.1-4* 

Please refer to relevant product direction for use for complete list of indications, contraindications and warnings. 

*Based on global Clareon® PanOptix® and AcrySof® IQ PanOptix® units sales 2021

†Pooled binocular defocus curve data from six individual studies. Snellen VA was converted from logMAR VA. A Snellen notation of 20/20^-2 or better indicates a logMAR VA of 0.04 or better, which means ≥3 of the 5 ETDRS chart letters in the line were identified correctly

1. Market Scope 2022 IOL Market Report

2. Alcon data on file, REF-18881, 2022

3. Clareon® PanOptix® Directions for Use_09/2021

4. Modi et al. Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens. 2020 Sep 28;S0161-6420(20)30677-1

5. Alcon data on file, REF-17351, 2022

6. Lwowski C, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive EDOF and trifocal intraocular lenses. J Cataract Refract Surg 2021 Aug 18. doi: 10.1097/j.jcrs.0000000000000780